{"transactions":[{"id":1500041,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T22:59:56.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":28650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date."}],"balance_after":28650,"derivative":{"exercise_price":0.82,"expiration_date":"2034-05-22","underlying":"Class A Common Stock","underlying_shares":28650},"source":{"system":"sec-edgar","filing":"0001380106-24-000140","document":"wk-form4_1716937188.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010624000140/wk-form4_1716937188.xml","form_type":"4"}},{"id":1500040,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-28T22:59:56.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date."}],"balance_after":14300,"source":{"system":"sec-edgar","filing":"0001380106-24-000140","document":"wk-form4_1716937188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010624000140/wk-form4_1716937188.xml","form_type":"4"}},{"id":1902289,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-05T22:01:51.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.8705,"expiration_date":"2033-05-03","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001380106-23-000079","document":"wf-form4_168332409394352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010623000079/wf-form4_168332409394352.xml","form_type":"4"}},{"id":2229500,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T16:33:27.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":27207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 15, 2022 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Option Date (the \"Next Annual Meeting\") occurs prior to the Vesting Date, then the option shall vest in full one day prior to the Next Annual Meeting."}],"balance_after":27207,"derivative":{"exercise_price":9.87,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":27207},"source":{"system":"sec-edgar","filing":"0001595585-22-000056","document":"wf-form4_165541157974491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000159558522000056/wf-form4_165541157974491.xml","form_type":"4"}},{"id":2235536,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T22:30:00.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":4.5,"expiration_date":"2032-05-22","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001127602-22-017266","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000112760222017266/form4.xml","form_type":"4"}},{"id":2241611,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T07:30:17.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2023."}],"balance_after":15000,"derivative":{"exercise_price":0.9728,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-021138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924322021138/doc4.xml","form_type":"4"}},{"id":2624914,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-26T20:30:30.000Z","date":"2021-07-23","kind":"grant","acquired":true,"shares":25833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the 2022 annual meeting of the Issuer's stockholders."}],"balance_after":25833,"derivative":{"exercise_price":8.63,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":25833},"source":{"system":"sec-edgar","filing":"0001209191-21-048256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919121048256/doc4.xml","form_type":"4"}},{"id":2629044,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":129032,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":129032,"derivative":{"exercise_price":0.05,"expiration_date":"2028-01-17","underlying":"Class A Common Stock","underlying_shares":129032},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629043,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Warrant","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":645160,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2028-01-17","underlying":"Series B1 Preferred Stock","underlying_shares":645160},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629042,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":500000,"derivative":{"exercise_price":0.05,"expiration_date":"2027-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629041,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Warrant","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2500000,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2027-07-24","underlying":"Series A1 Preferred Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629040,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C1 Preferred Stock","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2291665,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":458333},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629039,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Preferred Stock","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":5654529,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1130904},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629038,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Preferred Stock","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":8774007,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1754801},"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2629037,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-21T00:15:58.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":3344038,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":3407952,"source":{"system":"sec-edgar","filing":"0001104659-21-094107","document":"tm2122156-19_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921094107/tm2122156-19_4seq1.xml","form_type":"4"}},{"id":2633036,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T00:00:29.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable, subject to the Reporting Person's continued service to the Issuer's Board, in 36 substantially equal monthly installments with the first installment vesting on August 14, 2021."}],"balance_after":25000,"derivative":{"exercise_price":20,"expiration_date":"2031-07-13","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-092758","document":"tm2122156-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921092758/tm2122156-14_4seq1.xml","form_type":"4"}},{"id":2663819,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T17:03:02.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become fully exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the next annual meeting of the stockholders of the Issuer."}],"balance_after":20000,"derivative":{"exercise_price":8.98,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-041511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919121041511/doc4.xml","form_type":"4"}},{"id":2671322,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T18:29:53.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":57235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 10, 2021 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":57235,"derivative":{"exercise_price":4.92,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":57235},"source":{"system":"sec-edgar","filing":"0001595585-21-000082","document":"wf-form4_162345057774060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000159558521000082/wf-form4_162345057774060.xml","form_type":"4"}},{"id":2671321,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T18:29:53.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of June 10, 2021 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":27584,"source":{"system":"sec-edgar","filing":"0001595585-21-000082","document":"wf-form4_162345057774060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000159558521000082/wf-form4_162345057774060.xml","form_type":"4"}},{"id":2680685,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T16:30:39.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2022."}],"balance_after":15000,"derivative":{"exercise_price":8.98,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-022043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924321022043/doc4.xml","form_type":"4"}},{"id":3082728,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-07-15T17:00:11.000Z","date":"2020-07-14","kind":"exercise","acquired":false,"shares":491159,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power over securities held by LVP III. The reporting person is a member of LCP III and may be deemed to share voting, investment and dispositive power with respect to securities held by LVP III. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":393872},"source":{"system":"sec-edgar","filing":"0001209191-20-042498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042498/doc4.xml","form_type":"4"}},{"id":3082727,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-15T17:00:11.000Z","date":"2020-07-14","kind":"exercise","acquired":false,"shares":2581755,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power over securities held by LVP III. The reporting person is a member of LCP III and may be deemed to share voting, investment and dispositive power with respect to securities held by LVP III. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2070373},"source":{"system":"sec-edgar","filing":"0001209191-20-042498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042498/doc4.xml","form_type":"4"}},{"id":3082726,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-15T17:00:11.000Z","date":"2020-07-14","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power over securities held by LVP III. The reporting person is a member of LCP III and may be deemed to share voting, investment and dispositive power with respect to securities held by LVP III. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2714245,"source":{"system":"sec-edgar","filing":"0001209191-20-042498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042498/doc4.xml","form_type":"4"}},{"id":3082725,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-15T17:00:11.000Z","date":"2020-07-14","kind":"exercise","acquired":true,"shares":2464245,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power over securities held by LVP III. The reporting person is a member of LCP III and may be deemed to share voting, investment and dispositive power with respect to securities held by LVP III. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2464245,"source":{"system":"sec-edgar","filing":"0001209191-20-042498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042498/doc4.xml","form_type":"4"}},{"id":3084373,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T19:00:11.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable in 12 equal monthly installments from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":16,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-042313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042313/doc4.xml","form_type":"4"}},{"id":3110081,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T21:58:38.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":22967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 11, 2020 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":22967,"derivative":{"exercise_price":25.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22967},"source":{"system":"sec-edgar","filing":"0001628280-20-009469","document":"wf-form4_159227269916473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000162828020009469/wf-form4_159227269916473.xml","form_type":"4"}},{"id":3110080,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T21:58:38.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of June 11, 2020 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":11181,"source":{"system":"sec-edgar","filing":"0001628280-20-009469","document":"wf-form4_159227269916473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000162828020009469/wf-form4_159227269916473.xml","form_type":"4"}},{"id":3128878,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-01T17:09:20.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 28, 2021."}],"balance_after":15000,"derivative":{"exercise_price":15.43,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-014739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320014739/doc4.xml","form_type":"4"}},{"id":3131953,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T21:13:20.000Z","date":"2020-05-26","kind":"other","acquired":true,"shares":1649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Capital III to its members."}],"balance_after":1649,"source":{"system":"sec-edgar","filing":"0000899243-20-014484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320014484/doc4.xml","form_type":"4"}},{"id":3131952,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T21:13:20.000Z","date":"2020-05-26","kind":"other","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners III, L.P. (\"Longitude Venture III\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture III. The Reporting Person is a member of Longitude Capital Partners III, LLC (\"Longitude Capital III\"), the general partner of Longitude Venture III, and may be deemed to share voting, investment and dispositive power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":3199035,"source":{"system":"sec-edgar","filing":"0000899243-20-014484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320014484/doc4.xml","form_type":"4"}},{"id":3136891,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-05-22T20:24:39.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":8095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer."}],"balance_after":8095,"derivative":{"exercise_price":22.05,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":8095},"source":{"system":"sec-edgar","filing":"0001192482-20-000366","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000366/edgar.xml","form_type":"4"}},{"id":3136890,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T20:24:39.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":4047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":21164,"source":{"system":"sec-edgar","filing":"0001192482-20-000366","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000366/edgar.xml","form_type":"4"}},{"id":3350773,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T16:16:59.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":937500,"price":8,"value":7500000.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased pursuant to an underwritten public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 500 shares that were inadvertently omitted from the original Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting, investment and dispositive power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting, investment and dispositive power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4199035,"source":{"system":"sec-edgar","filing":"0000899243-19-028575","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319028575/doc4a.xml","form_type":"4/A","original_submission_date":"2019-11-27"}},{"id":3357273,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-27T16:43:35.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":937000,"price":8,"value":7496000.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased pursuant to an underwritten public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting, investment and dispositive power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting, investment and dispositive power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4198535,"source":{"system":"sec-edgar","filing":"0000899243-19-028236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319028236/doc4.xml","form_type":"4"}},{"id":3372722,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:33:57.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":25000,"price":19.33,"value":483250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.66, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17117,"source":{"system":"sec-edgar","filing":"0001192482-19-000406","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000406/edgar.xml","form_type":"4"}},{"id":3424779,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-09-03T22:16:46.000Z","date":"2019-08-29","kind":"exercise","acquired":false,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.33,"exercise_date":"2018-05-24","expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001192482-19-000352","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000352/edgar.xml","form_type":"4"}},{"id":3424778,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-03T22:16:46.000Z","date":"2019-08-29","kind":"sale","acquired":false,"shares":22106,"price":11.65,"value":257534.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.51 to $11.91, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42117,"source":{"system":"sec-edgar","filing":"0001192482-19-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000352/edgar.xml","form_type":"4"}},{"id":3424777,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-03T22:16:46.000Z","date":"2019-08-29","kind":"exercise","acquired":true,"shares":19853,"price":9.33,"value":185228.49,"ownership":{"direct":true},"balance_after":64223,"source":{"system":"sec-edgar","filing":"0001192482-19-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000352/edgar.xml","form_type":"4"}},{"id":3501693,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-04T20:28:45.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":7068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of May 31, 2019 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":7068,"derivative":{"exercise_price":36.74,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":7068},"source":{"system":"sec-edgar","filing":"0001595585-19-000106","document":"wf-form4_155969450987208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000159558519000106/wf-form4_155969450987208.xml","form_type":"4"}},{"id":3501692,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:28:45.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":1879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of May 31, 2019 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":5511,"source":{"system":"sec-edgar","filing":"0001595585-19-000106","document":"wf-form4_155969450987208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000159558519000106/wf-form4_155969450987208.xml","form_type":"4"}},{"id":3507364,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-30T19:55:55.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 29, 2020."}],"balance_after":15000,"derivative":{"exercise_price":8.21,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-015224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319015224/doc4.xml","form_type":"4"}},{"id":3546549,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-04-29T22:50:28.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":9414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable on April 25, 2020, subject to the director's continued service with the issuer."}],"balance_after":9414,"derivative":{"exercise_price":14.57,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":9414},"source":{"system":"sec-edgar","filing":"0001192482-19-000218","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000218/edgar.xml","form_type":"4"}},{"id":3546548,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T22:50:28.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":4707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 25, 2020, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,470 shares received in a distribution from Longitude Venture Partners, L.P. on August 14, 2018."}],"balance_after":44370,"source":{"system":"sec-edgar","filing":"0001192482-19-000218","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000218/edgar.xml","form_type":"4"}},{"id":3808129,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-25T16:18:09.000Z","date":"2018-09-21","kind":"purchase","acquired":true,"shares":365000,"price":5.5,"value":2007500.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners III, L.P. The Reporting Person is a member of Longitude Capital Partners III, LLC, the general partner of Longitude Venture Partners III, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":3261535,"source":{"system":"sec-edgar","filing":"0001209191-18-052147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000120919118052147/doc4.xml","form_type":"4"}},{"id":3878376,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":13147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, and subject to the Issuer's IPO closing on or before July 16, 2018, this option vests ratably on a monthly basis, on the monthly anniversary of June 27, 2018 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":13147,"derivative":{"exercise_price":19,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":13147},"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878375,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":1817447,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":456644},"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878374,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":9677419,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2431511},"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878373,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":3632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents restricted stock units (\"RSUs\") that, subject to the Issuer's initial public offering (\"IPO\") closing on or before July 16, 2018, vest on the earlier of (i) the one-year anniversary of June 27, 2018 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date.  Each RSU represents a contingent right to receive one share of Common Stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (\"RSUs\") that, subject to the Issuer's initial public offering (\"IPO\") closing on or before July 16, 2018, vest on the earlier of (i) the one-year anniversary of June 27, 2018 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date.  Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":3632,"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878372,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"purchase","acquired":true,"shares":131579,"price":19,"value":2500001.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3019734,"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878371,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":456644,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2888155,"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3878370,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-02T21:13:53.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":2431511,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date.  Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture Partners II, L.P. (\"Longitude II\"). Longitude Capital Partners II, LLC (\"LCP2\") is the general partner of Longitude II.  The Reporting Person is a member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this statement shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2431511,"source":{"system":"sec-edgar","filing":"0001140361-18-031067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595585/000114036118031067/form4.xml","form_type":"4"}},{"id":3908010,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T16:19:29.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on of May 31, 2019."}],"balance_after":15000,"derivative":{"exercise_price":6.31,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-014899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924318014899/doc4.xml","form_type":"4"}},{"id":3915225,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-05-29T21:02:54.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer."}],"balance_after":4506,"derivative":{"exercise_price":24.95,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":4506},"source":{"system":"sec-edgar","filing":"0001192482-18-000251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000251/edgar.xml","form_type":"4"}},{"id":3915224,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T21:02:54.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,940 shares received in distributions from Longitude Venture Partners, L.P. (\"LVP\") and Longitude Capital Associates, L.P. (\"LCA\")."}],"balance_after":27193,"source":{"system":"sec-edgar","filing":"0001192482-18-000251","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000251/edgar.xml","form_type":"4"}},{"id":4134581,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:23:59.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":19650,"price":17.34,"value":340731.0,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities held by Longitude Venture Partners, L.P. (\"LVP\") and Longitude Capital Associates, L.P. (\"LCA\"). Longitude Capital Partners, LLC (\"LCP\") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein."}],"balance_after":45620,"source":{"system":"sec-edgar","filing":"0001209191-17-065201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000120919117065201/doc4.xml","form_type":"4"}},{"id":4134580,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:23:59.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":980350,"price":17.34,"value":16999269.0,"ownership":{"direct":false,"nature":"By LVP"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities held by Longitude Venture Partners, L.P. (\"LVP\") and Longitude Capital Associates, L.P. (\"LCA\"). Longitude Capital Partners, LLC (\"LCP\") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein."}],"balance_after":2276222,"source":{"system":"sec-edgar","filing":"0001209191-17-065201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000120919117065201/doc4.xml","form_type":"4"}},{"id":4187926,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-11T19:55:13.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the total number of shares subject to the option shall vest on each of October 9, 2018 and October 9, 2019."}],"balance_after":25000,"derivative":{"exercise_price":9.4,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-024084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924317024084/doc4.xml","form_type":"4"}},{"id":4304741,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":90518,"kind":"person","name":"Hirsch David","position":1,"cik":"0001619884","reported_name":"Hirsch David","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2017-05-25T20:23:04.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer."}],"balance_after":19853,"derivative":{"exercise_price":9.33,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001192482-17-000133","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000133/edgar.xml","form_type":"4"}}]}